33769-07-2

Basic information

• Product Name: 1-TRITYL-1H-IMIDAZOLE-4-METHANOL
• Synonyms: RARECHEM AL BD 0931;4-HYDROXYMETHYL-1H-TRITYLIMIDAZOLE;1-TRITYL-IMIDOZOLE-4-METHANOL;1-TRITYL-1H-IMIDAZOLE-4-METHANOL;(1-TRITYL-1H-IMIDAZOL-4-YL)-METHANOL;4-(Hydroxymethyl)-1-trityl-1H-imidazole;1-(Triphenylmethyl)-4-(hydroxymethyl)imidazole;1-Triphenylmethyl-1H-imidazole-4-methanol
• CAS NO: 33769-07-2
• Molecular Formula: C₂₃H₂₀N₂O
• Molecular Weight: 340.42
• Product Categories: blocks;Imidazoles
• Mol File: 33769-07-2.mol
• Article Data: 75

Chemical Properties

• Melting Point: 226-232
• Boiling Point: 516.1 °C at 760 mmHg
• Flash Point: 265.9 °C
• Appearance: /
• Density: 1.1 g/cm³
• Vapor Pressure: 1.77E-11mmHg at 25°C
• Refractive Index: 1.612
• PKA: 13.61±0.10(Predicted)
• CAS DataBase Reference: 1-TRITYL-1H-IMIDAZOLE-4-METHANOL(CAS DataBase Reference)
• NIST Chemistry Reference: 1-TRITYL-1H-IMIDAZOLE-4-METHANOL(33769-07-2)
• EPA Substance Registry System: 1-TRITYL-1H-IMIDAZOLE-4-METHANOL(33769-07-2)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36/37/39
• Hazardous Substances Data: 33769-07-2(Hazardous Substances Data)

Usage

General Description

1-TRITYL-1H-IMIDAZOLE-4-METHANOL is a chemical compound that belongs to the class of imidazole derivatives. It is commonly used in organic synthesis and pharmaceutical research as a building block for the synthesis of various drugs and bioactive molecules. 1-TRITYL-1H-IMIDAZOLE-4-METHANOL is known for its ability to act as a versatile reagent in the formation of carbon-carbon and carbon-nitrogen bonds, making it a valuable tool in the production of complex organic compounds. Additionally, 1-TRITYL-1H-IMIDAZOLE-4-METHANOL has been studied for its potential therapeutic applications in the treatment of various diseases and disorders, highlighting its significance in the field of medicinal chemistry.

InChI:InChI=1/C23H20N2O/c26-17-22-16-25(18-24-22)23(19-10-4-1-5-11-19,20-12-6-2-7-13-20)21-14-8-3-9-15-21/h1-16,18,26H,17H2

Upstream product

• 822-55-9 (1H-imidazol-4-yl)methanol 
• 76-83-5 trityl chloride 
• 28697-53-2 D-arabinopyranose 
• 3473-63-0 formamidine acetic acid 
• 53525-60-3 4-carbethoxy-1-triphenyl methyl-1H-imidazole 
• 32673-41-9 1H-imidazol-5-ylmethanol hydrochloride 
• 32673-41-9 4-hydroxymethyl-1H-imidazole hydrochloride 
• 822-55-9 1H-imidazole-5-methanol 
• 121-44-8 triethylamine 
• 76074-88-9 methyl 1-(triphenylmethyl)-1H-imidazole-4-carboxylate 

Downstream Products

• 127056-57-9 4-(tert-butyldimethylsilyloxymethyl)-1-(triphenylmethyl)imidazole 
• 127717-93-5 4-<(trimethylsilyloxy)methyl>-1-(triphenylmethyl)imidazole 
• 82594-81-8 2-nitroimidazole-4-methanol 
• 191104-34-4 4-azidomethyl-1H-1-triphenylmethylimidazole 
• 33016-47-6 (1-tritylimidazol-4-yl)carboxaldehyde 
• 351019-69-7 (E)-N-{5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)-6-[1-(triphenylmethyl)imidazol-4-yl-methoxy]-pyrimidin-4-yl}-2-phenylethenesulfonamide 
• 103057-10-9 4-chloromethyl-1-tritylimidazole 
• 1056934-08-7 1-trityl-1H-imidazol-4-ylmethyl (tert-butyldimethylsilanyloxy)(4-cyanophenyl)acetate 
• 500782-72-9 C₄₂H₃₆N₄O₃ 
• 500782-77-4 C₃₄H₃₂N₄O 
• 500783-13-1 C₄₂H₄₅N₅O₄ 
• 500782-69-4 C₆₀H₅₂N₆O₃ 

Relevant articles and documents

Targeting GRP receptor: Design, synthesis and preliminary biological characterization of new non-peptide antagonists of bombesin

We report the rational design, synthesis, and in vitro preliminary evaluation of a new small library of non-peptide ligands of Gastrin Releasing Peptide Receptor (GRP-R), able to antagonize its natural ligand bombesin (BN) in the nanomolar range of concen

HETEROARYL RHEB INHIBITORS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same. Compositions comprising a compound of this invention or a pharmaceutically acceptable derivative thereof and a pharmaceutically acceptable carrier, adjuvant, or vehicle. The amount of the compound in compositions of this invention is such that it is effective to measurably inhibit Rheb, in a biological sample or in a patient.

Synthesis method of calmodulin inhibitor for treating brain-derived diseases

The invention discloses a synthesis method of a calmodulin inhibitor for treating brain-derived diseases and belongs to the technical field of synthesis of chemicals. The technical scheme is characterized in that a synthetic route of the synthesis method